BioN­Tech and Re­gen­eron ex­pand their can­cer part­ner­ship, push­ing new Lib­tayo com­bo in­to NSCLC

Af­ter go­ing back to the ne­go­ti­at­ing ta­ble, BioN­Tech and Re­gen­eron have come away with an ex­pand­ed col­lab­o­ra­tion push­ing their ef­forts in­to lung can­cer.

The two …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER